Twitter Logo Youtube Circle Icon LinkedIn Icon

Publishing firms

Legal Developments worldwide

China Drug Registration Regulation - Public consultation on amendment closes - March 2014

January 2015 - Corporate & Commercial. Legal Developments by Norton Rose Fulbright.

More articles by this firm.

In February 2014, the China Food and Drug Administration (“CFDA”) invited second-round comments from the public regarding proposed amendments to the China Drug Registration Regulations (“DRR”). One of the proposed amendments touches upon patent protection for drugs in China.

http://www.nortonrosefulbright.com/hk/knowledge/publications/114090/china-drug-registration-regulation